# Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)

> **NCT02471118** · PHASE2 · COMPLETED · sponsor: **CARE ARTHRITIS LTD.** · enrollment: 62 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** Adalimumab 40 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02471118
- **Lead sponsor:** CARE ARTHRITIS LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2021-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02471118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02471118, "Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02471118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*